EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy

Maria Fernanda Teixeira, Nicole Fahmy, Pashtoon Murtaza Kasi

Surgical Oncology Clinics of North America · 2026

DOI: 10.1016/j.soc.2025.12.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2026. Verfasst von Maria Fernanda Teixeira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Einstein Hospital Israelita, Albert Einstein 627, São Paulo, SP 05652-900, Brazil. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms, Immunotherapy, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Merck, Astellas Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsies offer a promising, noninvasive approach for monitoring and predicting responses to immunotherapy across multiple solid tumors. For the most part these are circulating tumor DNA (ctDNA) based assays. Here, we discuss the biological basis, clinical evidence, and potential applications of different types of ctDNA assays in tracking tumor dynamics, distinguishing pseudoprogression, and assessing minimal residual disease. We explore the current limitations, assay variability, and future directions, including integration with other biomarkers and real-world clinical trials aimed at validating ctDNA as a routine tool in precision immuno-oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNANeoplasmsImmunotherapyBiomarkers, TumorHumansLiquid BiopsyNeoplastic Cells, CirculatingNeoplasm, Residual

Stichwörter der Autor:innen

Circulating tumor DNACirculating tumor cellsImmune checkpoint inhibitorsImmunotherapy biomarkersLiquid biopsyMinimal residual diseasePseudopogressionctDNA

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Einstein Hospital Israelita, Albert Einstein 627, São Paulo, SP 05652-900, Brazil.
  • Department of Oncology and Therapeutics Research, City of Hope, 1500 Five Point, Irvine, CA 92618, USA.
  • Department of Oncology and Therapeutics Research, City of Hope, 1500 Five Point, Irvine, CA 92618, USA. Electronic address: kasi@coh.org.

Förderung

  • Merck
  • Astellas Pharma

Zitieren

APA

Teixeira, M. F., Fahmy, N., & Kasi, P. M. (2026). Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2025.12.010

Vancouver

Teixeira MF, Fahmy N, Kasi PM. Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy. Surgical Oncology Clinics of North America. 2026. doi:10.1016/j.soc.2025.12.010

BibTeX
@article{Teixeira2026,
  author = {Teixeira, Maria Fernanda and Fahmy, Nicole and Kasi, Pashtoon Murtaza},
  title = {Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy},
  journal = {Surgical Oncology Clinics of North America},
  year = {2026},
  doi = {10.1016/j.soc.2025.12.010}
}
Kostenlos starten →